Search Results - Kenji Morikami
- Showing 1 - 2 results of 2
-
1
The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor by Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi, Toshihiko Fujii, Kiyoaki Sakata, Hitoshi Sase, Takehito Isobe, Kenji Morikami, Hidetoshi Shindoh, Toshiyuki Mio, Hirosato Ebiike, Naoki Taka, Yuko Aoki, Nobuya Ishii
Published 2014Artigo -
2
Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors by Piro Lito, Anna Saborowski, Jingyin Yue, Martha Solomon, Eric W. Joseph, Sunyana Gadal, Michael Saborowski, Edward R. Kastenhuber, Christof Fellmann, Kazuhiro Ohara, Kenji Morikami, Takaaki Miura, Christine Lukacs, Nobuya Ishii, Scott W. Lowe, Neal Rosen
Published 2014Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Biochemistry
Cancer
Cell biology
Cell culture
Chemistry
Fibroblast growth factor
Fibroblast growth factor receptor
Gene
Gene knockdown
Genetics
Internal medicine
KRAS
MAPK/ERK pathway
MEK inhibitor
Medicine
Melanoma
Mutant
Mutation
Pharmacology
Phosphorylation
Receptor
Selumetinib
Trametinib
V600E